Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

By  

Current HIV Research, Vol. 14, Iss. 1, 2016-01 ,pp. : 61-70

Bentham Science Publishers

Access to resources Recommend Favorite

Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment

By Préau M.   Leport C.   Salmon-ceron D.   Carrieri P.   Portier H.   Chene G.   Spire B.   Choutet P.   Raffi F.   Morin M.  

AIDS Care, Vol. 16, Iss. 5, 2004-07 ,pp. : 649-661

Routledge Ltd

Access to resources Recommend Favorite

Resistance-Associated Mutations after Initial Antiretroviral Treatment Failure in a Large Cohort of Patients Infected with HIV-1 Subtype CRF01_AE

By  

Current HIV Research, Vol. 10, Iss. 8, 2012-12 ,pp. : 647-652

Bentham Science Publishers

Access to resources Recommend Favorite

The impact of British and US guidelines for initiating combination antiretroviral therapy on estimating national treatment requirements for HIV-positive patients

By Parpia T.   Raab G. M.   Goldberg D. J.   Whitelaw J.   Galloway E.   Potts R.  

AIDS Care, Vol. 11, Iss. 6, 1999-12 ,pp. : 699-709

Routledge Ltd

Access to resources Recommend Favorite

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment

By Mamori Satoshi   Suzuki Fumitaka   Hosaka Tetsuya   Akuta Norio   Someya Takashi   Kobayashi Masahiro   Tsubota Akihito   Suzuki Yoshiyuki   Saitoh Satoshi   Arase Yasuji   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 8, 2004-08 ,pp. : 776-782

Springer Publishing Company

Access to resources Recommend Favorite